产品编号:GM-88254MAB
产品名称:Anti-Mouse_PD1×VEGF hIgG1 Bispecific Antibody
目录价:询价

产品编号:GM-88254MAB
产品名称:Anti-Mouse_PD1×VEGF hIgG1 Bispecific Antibody
目录价:询价

GM-88254MAB-1mg / 1 mg
GM-88254MAB-5mg / 5 mg
GM-88254MAB-25mg / 5 mg * 5 vials
GM-88254MAB-50mg / 50 mg
GM-88254MAB-100mg / 50 mg * 2 vials
Expression System  | CHO  | 
Aggregation  | < 5% as determined by SEC-HPLC  | 
Purity  | > 95% as determined by SDS-PAGE  | 
Endotoxin  | < 1 EU/mg, determined by LAL gel clotting assay  | 
Sterility  | 0.2 μm Filtered  | 
Target  | VEGF&PD1  | 
Alternative Names  | PD1: CD279 VEGF: VPF; MVCD1; L-VEGF  | 
Source/Isotype  | Monoclonal human IgG1 D265A, Kappa  | 
Application  | Flow cytometry; Block assay  | 
Description  | PD-1/VEGF Bispesific Antibody is a novel cancer immunotherapy drug that can target both PD-1 and VEGF. It blocks the interaction between PD-1 and PD-L1/PD-L2. The bispecific antibody can specifically bind to VEGFA and PD-1, selectively relieve the immune suppression caused by VEGFA and PD-1 in the body, and inhibit tumor-induced angiogenesis.  | 
Formulation  | 20 mM Histidine, 150 mM NaCl, pH6.0  | 




产品编号:GM-88254MAB
产品名称:Anti-Mouse_PD1×VEGF hIgG1 Bispecific Antibody
目录价:询价

GM-88254MAB-1mg / 1 mg
GM-88254MAB-5mg / 5 mg
GM-88254MAB-25mg / 5 mg * 5 vials
GM-88254MAB-50mg / 50 mg
GM-88254MAB-100mg / 50 mg * 2 vials
Expression System  | CHO  | 
Aggregation  | < 5% as determined by SEC-HPLC  | 
Purity  | > 95% as determined by SDS-PAGE  | 
Endotoxin  | < 1 EU/mg, determined by LAL gel clotting assay  | 
Sterility  | 0.2 μm Filtered  | 
Target  | VEGF&PD1  | 
Alternative Names  | PD1: CD279 VEGF: VPF; MVCD1; L-VEGF  | 
Source/Isotype  | Monoclonal human IgG1 D265A, Kappa  | 
Application  | Flow cytometry; Block assay  | 
Description  | PD-1/VEGF Bispesific Antibody is a novel cancer immunotherapy drug that can target both PD-1 and VEGF. It blocks the interaction between PD-1 and PD-L1/PD-L2. The bispecific antibody can specifically bind to VEGFA and PD-1, selectively relieve the immune suppression caused by VEGFA and PD-1 in the body, and inhibit tumor-induced angiogenesis.  | 
Formulation  | 20 mM Histidine, 150 mM NaCl, pH6.0  | 



